Impact of CYP2C19 variants on drug efficacy of clopidogrel and 1-year clinical outcomes in coronary heart patients undergoing PCI

被引：0
|
作者：
Hong, Sun [1 ]
Sun, Hong [1 ]
Chen, Hui [2 ]
机构：
[1] Fujian Med Univ, Fujian Prov Hosp, Dept Pharm, Prov Clin Coll, Fuzhou, Peoples R China
[2] Fujian Med Univ, Fujian Prov Cardiovasc Dis Inst, Prov Clin Coll, Hypertens Lab, Fuzhou, Fujian Province, Peoples R China
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 68卷 / 16期
关键词：
D O I：
10.1016/j.jacc.2016.07.389
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
GW27-e0434
引用
收藏
页码：C104 / C104
页数：1
相关论文
共 50 条
  • [21] CYP2C19 genotypes and their impact on clopidogrel responsiveness in percutaneous coronary intervention
    Melissa Mejin
    Wen Ni Tiong
    Lana Yin Hui Lai
    Lee Len Tiong
    Adam Mohamad Bujang
    Siaw San Hwang
    Tiong Kiam Ong
    Alan Yean Yip Fong
    International Journal of Clinical Pharmacy, 2013, 35 : 621 - 628
  • [22] Impact of Glycemic Control on Efficacy of Clopidogrel in Transient Ischemic Attack or Minor Stroke Patients With CYP2C19 Genetic Variants
    Lin, Yi
    Wang, Anxin
    Li, Jiejie
    Lin, Jinxi
    Wang, David
    Meng, Xia
    Ou, Lixian
    Chen, Weiqi
    Zhao, Xingquan
    Liu, Liping
    Wang, Yilong
    Wang, Yongjun
    STROKE, 2017, 48 (04) : 998 - 1004
  • [23] Cyp2c19 Polymorphisms Are Not Associated With the Longterm Clinical Outcomes in Stroke Patients Treated With Clopidogrel
    Tanaka, Tomotaka
    Yamagami, Hiroshi
    Ihara, Masafumi
    Hamasaki, Toshimitsu
    Miyata, Shigeki
    Miyata, Toshiyuki
    Yamamoto, Haruko
    Toyoda, Kazunori
    Nagatsuka, Kazuyuki
    STROKE, 2016, 47
  • [24] Effect of PON1 and CYP2C19 genetic variants on clinical outcomes in young patients treated with clopidogrel after myocardial infarction
    Hulot, J-S
    Collet, J-P
    Cayla, G.
    Silvain, J.
    Finzi, J.
    Allanic, F.
    Bellemain-Appaix, A.
    Anzaha, G.
    Montalescot, G.
    EUROPEAN HEART JOURNAL, 2011, 32 : 28 - 29
  • [25] Prevalence of CYP2C19*2 and CYP2C19*3 Allelic Variants and Clopidogrel Use in Patients with Cardiovascular Disease in Trinidad & Tobago
    Daniele Jones
    Shana Persad-Ramdeensingh
    Sheherazade Crystal Abrahim
    Naveen Seecheran
    Rajini Rani Haraksingh
    Cardiology and Therapy, 2024, 13 : 191 - 203
  • [26] Impact of CYP2C19 genotype and platelet function on clinical outcome in coronary atherosclerotic heart diseases patients receiving clopidogrel post percutaneous coronary intervention
    吴瑛
    ChinaMedicalAbstracts(InternalMedicine), 2017, 34 (03) : 164 - 164
  • [27] Prevalence of CYP2C19*2 and CYP2C19*3 Allelic Variants and Clopidogrel Use in Patients with Cardiovascular Disease in Trinidad & Tobago
    Jones, Daniele
    Persad-Ramdeensingh, Shana
    Abrahim, Sheherazade Crystal
    Seecheran, Naveen
    Haraksingh, Rajini Rani
    CARDIOLOGY AND THERAPY, 2024, 13 (01) : 191 - 203
  • [28] Impact of CYP2C19 Polymorphisms on Clinical Outcomes and Antiplatelet Potency of Clopidogrel in Caucasian Poststroke Survivors
    Tomek, Ales
    Mat'oska, Vaclav
    Frydmanova, Alena
    Magerova, Hana
    Sramek, Martin
    Paulasova-Schwabova, Jaroslava
    Ruzickova, Tereza
    Jansky, Petr
    Sarbochova, Ivana
    Hadacova, Ivana
    Kaplan, Vojtech
    Lacinova, Zuzana
    Taborsky, Ludek
    Serebruany, Victor
    AMERICAN JOURNAL OF THERAPEUTICS, 2018, 25 (02) : E202 - E212
  • [29] Influence of Smoking on CYP2C19 Genetic Variants and Clopidogrel Efficacy in Patients with Minor Stroke or TIA.
    Wang, Tingting
    Pan, Yuesong
    Lin, Jinxi
    Anand, Raja
    Johnston, S. Claiborne
    Wang, Yongjun
    Wang, Yilong
    STROKE, 2019, 50
  • [30] Impact of CYP2C19 polymorphism and smoking on response to clopidogrel in patients with stable coronary artery disease
    Liu Xiao-li
    Wang Zhi-jian
    Yang Qing
    Ge Hai-long
    Gao Fei
    Liu Yu-yang
    Shi Dong-mei
    Zhao Ying-xin
    Zhou Yu-jie
    CHINESE MEDICAL JOURNAL, 2010, 123 (22) : 3178 - 3183
12345